AU4008597A – The new use of dicaffeoylquinic acid for treating hepatitis b and the diseases related with retrovirus, and the new caffeoylquinic acid derivatives
– Google Patents
AU4008597A – The new use of dicaffeoylquinic acid for treating hepatitis b and the diseases related with retrovirus, and the new caffeoylquinic acid derivatives
– Google Patents
The new use of dicaffeoylquinic acid for treating hepatitis b and the diseases related with retrovirus, and the new caffeoylquinic acid derivatives
Info
Publication number
AU4008597A
AU4008597A
AU40085/97A
AU4008597A
AU4008597A
AU 4008597 A
AU4008597 A
AU 4008597A
AU 40085/97 A
AU40085/97 A
AU 40085/97A
AU 4008597 A
AU4008597 A
AU 4008597A
AU 4008597 A
AU4008597 A
AU 4008597A
Authority
AU
Australia
Prior art keywords
new
retrovirus
diseases related
treating hepatitis
acid derivatives
Prior art date
1996-08-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU40085/97A
Inventor
Junxing Dong
Zhibao Mi
Zhongming Tang
Bingji Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Radiation Medicine of CAMMS
Original Assignee
Institute of Radiation Medicine of CAMMS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1996-08-29
Filing date
1997-08-27
Publication date
1998-03-26
1997-08-27
Application filed by Institute of Radiation Medicine of CAMMS
filed
Critical
Institute of Radiation Medicine of CAMMS
1998-03-26
Publication of AU4008597A
publication
Critical
patent/AU4008597A/en
Status
Abandoned
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
A61P31/12—Antivirals
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
A61P31/12—Antivirals
A61P31/14—Antivirals for RNA viruses
A61P31/18—Antivirals for RNA viruses for HIV
AU40085/97A
1996-08-29
1997-08-27
The new use of dicaffeoylquinic acid for treating hepatitis b and the diseases related with retrovirus, and the new caffeoylquinic acid derivatives
Abandoned
AU4008597A
(en)
Applications Claiming Priority (3)
Application Number
Priority Date
Filing Date
Title
CN96111691
1996-08-29
CN96111691A
CN1087608C
(en)
1996-08-29
1996-08-29
Use of dicafeoyl quininic acid in treatment of hepatitis B and diseases associated with retrovirus and cafeoyl quininic acid derivs.
PCT/CN1997/000087
WO1998009599A2
(en)
1996-08-29
1997-08-27
The new use of dicaffeoylquinic acid for treating hepatitis b and the diseases related with retrovirus, and the new caffeoylquinic acid derivatives
Publications (1)
Publication Number
Publication Date
AU4008597A
true
AU4008597A
(en)
1998-03-26
Family
ID=5121229
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU40085/97A
Abandoned
AU4008597A
(en)
1996-08-29
1997-08-27
The new use of dicaffeoylquinic acid for treating hepatitis b and the diseases related with retrovirus, and the new caffeoylquinic acid derivatives
Country Status (8)
Country
Link
US
(1)
US6331565B1
(en)
EP
(1)
EP1008344B1
(en)
JP
(1)
JP4219986B2
(en)
CN
(1)
CN1087608C
(en)
AU
(1)
AU4008597A
(en)
BR
(1)
BR9711647A
(en)
DE
(1)
DE69734296T2
(en)
WO
(1)
WO1998009599A2
(en)
Families Citing this family (18)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
CN1093529C
(en)
*
1999-04-16
2002-10-30
中国人民解放军军事医学科学院放射医学研究所
Preparation of 1,5-di-o-coffeic acyl quininic acid derivative
TW200817024A
(en)
*
2000-04-10
2008-04-16
Takara Bio Inc
Remedies
US6632459B2
(en)
2000-12-11
2003-10-14
Nutricia N.V.
Chlorogenic acid and an analog thereof for immune system stimulation
CN100353938C
(en)
*
2004-09-29
2007-12-12
中国人民解放军军事医学科学院放射与辐射医学研究所
Composition containing dicaffeoyl quinic acid and its preparing method
CN100341500C
(en)
*
2004-09-29
2007-10-10
中国人民解放军军事医学科学院放射与辐射医学研究所
Emulsion containing dicaffeoyl quinic acid and its preparing method
EP1671535A1
(en)
2004-12-16
2006-06-21
Stiftung Caesar Center of Advanced European Studies and Research
Methods for altering levels of phenolic compounds in plant cells
JP4586119B2
(en)
*
2005-10-28
2010-11-24
独立行政法人科学技術振興機構
Hepatitis C virus production suppression material and its production method
CN1899279A
(en)
*
2005-07-22
2007-01-24
四川九章生物化工科技发展有限公司
Use of chlorogenic acid in preparing medicine with liver protective efficiency
CN1879727B
(en)
*
2006-05-09
2010-04-21
中国科学院上海药物研究所
Novel hepatitis B inhibitor and application thereof
CN101185668A
(en)
*
2006-11-15
2008-05-28
广州联创思远利生物科技有限公司
Novel preparation for preventing and controlling acquired immuno-deficiency syndrome and protecting liver and detoxication
JP4621855B2
(en)
*
2007-01-17
2011-01-26
雲海酒造株式会社
Liver protective agent, hepatocarcinogenesis inhibitor, and pharmaceutical compositions thereof
CN101245068A
(en)
2007-02-14
2008-08-20
浙江医药股份有限公司新昌制药厂
Crystallization type entecavir, method of producing the same, pharmaceutical composition and uses thereof
CN101284799B
(en)
*
2007-03-23
2013-04-03
浙江医药股份有限公司新昌制药厂
Nitrogen-contained derivates of caffeoylquinic acid, method for preparing same, pharmaceutical compositions thereof and uses
CN101397333A
(en)
2007-09-27
2009-04-01
浙江医药股份有限公司新昌制药厂
De-hydroxyl vancomycin, preparation method thereof, medicament composition and use thereof
FR2926955B1
(en)
2008-02-01
2012-07-20
Agronomique Inst Nat Rech
PROCESS FOR THE PREPARATION OF DICAFEOYLQUINIC ACIDS AND THEIR USE IN THE FIGHT AGAINST PUCERONS
CN101828693B
(en)
2009-03-09
2013-01-02
浙江医药股份有限公司新昌制药厂
Preparation method and application of low-viscosity high-fluidity carotenoid oil suspension
CN101829077B
(en)
*
2010-05-26
2012-01-18
中国药科大学
Application of dicaffeoyl-quinic acid derivative in preparing drugs for treating mycoplasma infection diseases
CN114652710A
(en)
*
2022-04-01
2022-06-24
北京济全生物科技有限公司
Application of 1, 3-dicaffeoylquinic acid in preparing medicine for treating liver cancer
Family Cites Families (3)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
IT1050371B
(en)
*
1973-07-05
1981-03-10
Simes
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF LIVER DISEASES
US6355684B1
(en)
*
1990-10-11
2002-03-12
Meryl J. Squires
Antimicrobial treatment for herpes simplex virus and other infectious diseases
FR2693105B1
(en)
*
1992-07-01
1994-09-02
Oreal
Cosmetic and / or dermatological composition with depigmenting action containing a di- or tri-caféoylquinic acid or a mixture of these.
1996
1996-08-29
CN
CN96111691A
patent/CN1087608C/en
not_active
Expired – Fee Related
1997
1997-08-27
AU
AU40085/97A
patent/AU4008597A/en
not_active
Abandoned
1997-08-27
EP
EP97937407A
patent/EP1008344B1/en
not_active
Expired – Lifetime
1997-08-27
JP
JP51208798A
patent/JP4219986B2/en
not_active
Expired – Fee Related
1997-08-27
BR
BR9711647-5A
patent/BR9711647A/en
not_active
Application Discontinuation
1997-08-27
DE
DE69734296T
patent/DE69734296T2/en
not_active
Expired – Lifetime
1997-08-27
WO
PCT/CN1997/000087
patent/WO1998009599A2/en
active
IP Right Grant
1999
1999-03-01
US
US09/260,740
patent/US6331565B1/en
not_active
Expired – Lifetime
Also Published As
Publication number
Publication date
WO1998009599A3
(en)
1998-06-04
EP1008344A4
(en)
2003-09-17
JP4219986B2
(en)
2009-02-04
WO1998009599A2
(en)
1998-03-12
US6331565B1
(en)
2001-12-18
JP2000517323A
(en)
2000-12-26
EP1008344A2
(en)
2000-06-14
EP1008344B1
(en)
2005-09-28
CN1087608C
(en)
2002-07-17
CN1175411A
(en)
1998-03-11
BR9711647A
(en)
2000-06-06
DE69734296T2
(en)
2006-07-06
DE69734296D1
(en)
2006-02-09
Similar Documents
Publication
Publication Date
Title
AU4008597A
(en)
1998-03-26
The new use of dicaffeoylquinic acid for treating hepatitis b and the diseases related with retrovirus, and the new caffeoylquinic acid derivatives
AU4342997A
(en)
1998-04-02
Use of quinazoline derivatives for the manufacture of a medicament in the reatment of hyperproliferative skin disorders
IL109579A0
(en)
1994-08-26
Bile acid derivatives, processes for their preparation and the use of these compounds as medicaments
IS1812B
(en)
2002-05-15
Therapeutic compounds, pharmaceutically acceptable salts and compositions containing the compounds, together with their use
ITRM920412D0
(en)
1992-05-29
HETEROPROSTANOIDS, PROCEDURE FOR THEIR PREPARATION AND THEIR EMPLOYE THERAPEUTIC.
FI956298A0
(en)
1995-12-28
3-Phenyl-isoquinolin-1 (2H) -ones, their preparation and therapeutic use
IL129144A0
(en)
2000-02-17
Use of 1-hydroxy-2-pyridones for the treatment of skin diseases
AU7277598A
(en)
1998-11-24
Energy delivery of catheter and method for the use thereof
AU2821295A
(en)
1996-01-05
Compositions and methods for the treatment of tumors
IL127739A0
(en)
1999-10-28
Retinoyloxy (substituted) alkylene butyrates useful for the treatment of cancer and other proliferative diseases
AU3695297A
(en)
1998-02-10
Alfa-amino acid amides, preparation thereof and the therapeutical use thereof
AU3684395A
(en)
1996-05-02
Use of camptothecin or derivatives thereof for the manufacture of a medicament for the treatment of viral diseases
AU7653600A
(en)
2001-04-30
Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis
AU1388999A
(en)
1999-07-05
The use of nitric oxide generations for the treatment of dry eye disorders
NO321411B1
(en)
2006-05-08
Use of kalpastatin for the preparation of a composition for the treatment of cancer
AU2462097A
(en)
1998-04-24
The use of a substance p antagonist for the manufacture of medicament for the treatment of ocular pain
AU8049098A
(en)
1998-12-30
Composition and methods for the treatment of inflammatory diseases
AU1801297A
(en)
1997-09-02
Spiro-ketal derivatives and their use as therapeutic agents
AU5903690A
(en)
1991-01-17
Use in therapy of 10-amino-5,6-dihydro-11h-dibenzo(b,e) azepine-6, 11-dione and derivatives as drugs for use in the treatment of urinary incontinence
HRP940124A2
(en)
1997-10-31
Novel sulfonamidodioxepanes, methods of preparation, intermediates, salts and the use thereof
AU4114196A
(en)
1996-06-19
Combination therapy with estriol and vitamin a, c or e for preventing/treating arterial diseases
AU5766898A
(en)
1998-08-18
Mixtures of 1,3-diol-based esters, process for the preparation of 1,3-diol-basedesters and the use thereof
FI935575A
(en)
1994-06-15
3- (Quinolin-6-ylmethyl) -4H-imidazol-4-one derivatives, process for their preparation and their therapeutic use
GC0000176A
(en)
2006-03-29
Pharmaceutical combination preparations for the treatment of cardiac disorders
AU3651595A
(en)
1996-04-09
Drug for the prevention and treatment of auto-immune and viral diseases, and diagnostic agents for detecting said diseases
None